KemNet provides pharmacists with revised formulations of popular pharmaceuticals tailored to specific patient demographics. This approach enhances therapeutic outcomes by addressing the unique needs of these groups, ensuring more effective medication management.
Funding
Funding not disclosed
Founders
Product
Problem
Many pharmaceutical formulations are designed for the average patient, potentially overlooking the unique physiological and metabolic differences within specific demographic groups. This one-size-fits-all approach can lead to suboptimal therapeutic outcomes and increased adverse effects in certain populations.
Solution
KemNet offers reformulated versions of widely prescribed medications, customized to address the distinct needs of particular patient demographics. By considering factors such as age, sex, ethnicity, and genetic predispositions, KemNet aims to optimize drug efficacy and minimize potential side effects. This targeted approach allows healthcare providers to prescribe medications that are better suited to individual patient profiles, leading to improved treatment outcomes and enhanced patient safety.
Target Audience
KemNet's primary customers are pharmacists, physicians, and healthcare providers seeking to improve medication management and patient outcomes through personalized pharmaceutical solutions.
Features
- Reformulation of existing pharmaceuticals based on demographic-specific pharmacokinetic and pharmacodynamic data.
- Clinical trials to validate the safety and efficacy of reformulated medications in target populations.
- Partnerships with pharmaceutical manufacturers to produce and distribute customized drug formulations.
- Development of proprietary algorithms to identify patient subgroups that would benefit most from reformulated medications.